Last reviewed · How we verify

NCT06122818

Evaluation of Sarcopenia in Patients Receiving Home Health Care

Completed Last updated 20 November 2024
What this trial tests

trial testing Immobile patients receiving home health care in Sarcopenia in 120 participants. Completed in 5 October 2024.

Timeline
6 November 2023
Primary endpoint
1 October 2024
5 October 2024

Quick facts

Lead sponsorIstanbul Physical Medicine Rehabilitation Training and Research Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment120
Start date6 November 2023
Primary completion1 October 2024
Estimated completion5 October 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Istanbul Physical Medicine Rehabilitation Training and Research Hospital

Who can join

Adults 18 to 85, any sex, with Sarcopenia or Home Health Care. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim in the study is to evaluate the presence of sarcopenia in patients receiving home health care; To evaluate the relationship between sarcopenia and age, disease duration, and cause of immobility. In the literature review, a limited number of studies evaluating sarcopenia in home health patients were found.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Sarcopenia

Currently open trials in the same condition.

Other Istanbul Physical Medicine Rehabilitation Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06122818.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing